Kolon Life Science signs ‘INVOSSA’ export agreement to Saudi Arabia and UAE

Published: 2018-06-28 16:32:24

Updated: 2018-06-28 16:32:24

Kolon Life Science(CEO Woo-Seok Lee) signed an exclusive sales & export agreement with Mundipharma as a strategic partner to enter Saudi Arabia and the United Arab Emirates(UAE) with ‘INVOSSA®-K,’ the first knee osteoarthritis therapy.

The agreement is the first case of entering the Middle East for the company with the product other than current Asian countries. Mundipharma will take the proce...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.